(0.05%) 5 519.50 points
(0.12%) 39 891 points
(0.12%) 19 775 points
(-0.04%) $81.60
(0.43%) $2.82
(-0.26%) $2 338.20
(0.14%) $29.57
(0.40%) $1 005.80
(0.07%) $0.932
(-0.08%) $10.53
(-0.01%) $0.788
(-0.85%) $87.25
0.00% $ 0.0251
Live Chart Being Loaded With Signals
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore...
Stats | |
---|---|
Dzisiejszy wolumen | 10 000 |
Średni wolumen | 9 129 |
Kapitalizacja rynkowa | 771 519 |
EPS | $-0.0932 ( Q3 | 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.110 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Konar Shameek | Buy | 4 090 908 | Warrants to Purchase Common Stock |
2023-12-29 | Konar Shameek | Buy | 0 | 12.0% Senior Secured Convertible Notes |
2023-12-27 | Konar Shameek | Buy | 0 | Common Stock |
2023-09-11 | Konar Shameek | Buy | 513 447 | Warrants to Purchase Common Stock |
2023-12-29 | Denny George P Iii | Buy | 3 913 526 | Warrants to Purchase Common Stock |
INSIDER POWER |
---|
86.77 |
Last 85 transactions |
Buy: 62 024 865 | Sell: 5 604 873 |
Comera Life Sciences Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Comera Life Sciences Finanse
Annual | 2022 |
Przychody: | $633 102 |
Zysk brutto: | $422 712 (66.77 %) |
EPS: | $-2.30 |
FY | 2022 |
Przychody: | $633 102 |
Zysk brutto: | $422 712 (66.77 %) |
EPS: | $-2.30 |
FY | 2021 |
Przychody: | $319 832 |
Zysk brutto: | $158 824 (49.66 %) |
EPS: | $-0.286 |
FY | 2020 |
Przychody: | $442 919 |
Zysk brutto: | $338 512 (76.43 %) |
EPS: | $-0.111 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Comera Life Sciences
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn\'s and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej